Krela-Kaźmierczak I - Search Results

1

The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.

Eder P, Katulska K, Krela-Kaźmierczak I, Stawczyk-Eder K, Klimczak K, Szymczak A, Linke K, Łykowska-Szuber L. Eder P, et al. Abdom Imaging. 2015 Oct;40(7):2210-8. doi: 10.1007/s00261-015-0466-0. Abdom Imaging. 2015. PMID: 26048698 Free PMC article.

2

Clinical utility of the assessment of fecal calprotectin in Leśniowski-Crohn's disease.

Eder P, Stawczyk-Eder K, Krela-Kaźmierczak I, Linke K. Eder P, et al. Pol Arch Med Wewn. 2008 Nov;118(11):622-6. Pol Arch Med Wewn. 2008. PMID: 19140565 Free article.

3

The influence of infliximab and adalimumab on the expression of apoptosis-related proteins in lamina propria mononuclear cells and enterocytes in Crohn's disease - an immunohistochemical study.

Eder P, Lykowska-Szuber L, Krela-Kazmierczak I, Stawczyk-Eder K, Zabel M, Linke K. Eder P, et al. J Crohns Colitis. 2013 Oct;7(9):706-16. doi: 10.1016/j.crohns.2012.09.006. Epub 2012 Sep 27. J Crohns Colitis. 2013. PMID: 23021876

4

Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease.

Eder P, Lykowska-Szuber L, Krela-Kazmierczak I, Stawczyk-Eder K, Linke K. Eder P, et al. Acta Gastroenterol Belg. 2013 Mar;76(1):74-5. Acta Gastroenterol Belg. 2013. PMID: 23650791 Free article. No abstract available.

5

Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.

Eder P, Katulska K, Lykowska-Szuber L, Stawczyk-Eder K, Krela-Kaźmierczak I, Linke K. Eder P, et al. Pol Arch Med Wewn. 2013;123(7-8):378-85. doi: 10.20452/pamw.1825. Epub 2013 Jun 14. Pol Arch Med Wewn. 2013. PMID: 23778300 Free article.

6

Anti-TNF antibodies do not induce the apoptosis of lamina propria mononuclear cells in uninflamed intestinal tissue in patients with Crohn's disease.

Eder P, Lykowska-Szuber L, Krela-Kazmierczak I, Stawczyk-Eder K, Sterzynska K, Iwanik K, Majewski P, Zabel M, Linke K. Eder P, et al. Folia Histochem Cytobiol. 2013;51(3):239-43. doi: 10.5603/FHC.2013.0034. Folia Histochem Cytobiol. 2013. PMID: 24203631 Free article. Clinical Trial.

7

Association between disease duration and usefulness of fecal calprotectin measurement in patients with Crohn's disease.

Eder P, Stawczyk-Eder K, Łykowska-Szuber L, Krela-Kaźmierczak I, Klimczak K, Szymczak A, Szachta P, Linke K. Eder P, et al. Pol Arch Med Wewn. 2014;124(1-2):51-7. Epub 2013 Dec 4. Pol Arch Med Wewn. 2014. PMID: 24424551 Free article.

8

Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases.

Eder P, Lykowska-Szuber L, Stawczyk-Eder K, Krela-Kaźmierczak I, Linke K. Eder P, et al. Prz Gastroenterol. 2014;9(5):275-9. doi: 10.5114/pg.2014.46162. Epub 2014 Oct 19. Prz Gastroenterol. 2014. PMID: 25396001 Free PMC article. Review.

9

Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies.

Eder P, Michalak M, Katulska K, Lykowska-Szuber L, Krela-Kazmierczak I, Stawczyk-Eder K, Klimczak K, Szymczak A, Linke K. Eder P, et al. Sci Rep. 2015 May 20;5:10223. doi: 10.1038/srep10223. Sci Rep. 2015. PMID: 25993615 Free PMC article.

10

Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study.

Stawczyk-Eder K, Eder P, Lykowska-Szuber L, Krela-Kazmierczak I, Klimczak K, Szymczak A, Szachta P, Katulska K, Linke K. Stawczyk-Eder K, et al. Arch Med Sci. 2015 Apr 25;11(2):353-61. doi: 10.5114/aoms.2014.43672. Epub 2015 Apr 23. Arch Med Sci. 2015. PMID: 25995752 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters